https://doi.org/10.4081/monaldi.2025.3406
Diagnostic yield and complications of thoracic ultrasound-guided biopsy performed by pulmonologists
Accepted: February 7, 2025
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
Interventional pulmonology is a growing field in India, and adding thoracic ultrasound (TUS)-guided lung biopsy can be useful for interventional pulmonologists. This study evaluated whether TUS-guided lung biopsy performed by pulmonologists, without the help of radiologists, can accurately diagnose pulmonary disease. A single-center prospective study was conducted with patients with pulmonary lesions requiring transthoracic biopsy. The primary objective was to find out the time taken by an experienced pulmonologist for the procedure without the aid of a radiologist. The secondary objective included the diagnostic yield of TUS-guided lung biopsy performed by a pulmonologist and the complication rate of the procedure. The study included 88 patients aged 18 to 86 years with a mean age of 62.7±12.9 years. The mean time taken for biopsy was 13±2.42 minutes. A total of 68 (77.2%) cases were biopsied in 11-15 minutes. Diagnosis could be established in 88.5% of cases. Pain at the biopsy site was the most common complication seen in 11 (12.5%) cases. Hemoptysis and bleeding at the biopsy site were seen in 7 (7.95%) cases. Pneumothorax was seen in 2 (2.27%) cases. Air embolism, post-procedure intubation, and malfunctioning of the forceps were seen in 1 (1.14%) case. TUS-guided lung biopsy performed by a pulmonologist without the help of a radiologist has a diagnostic yield similar to that performed by radiologists but can take a shorter time. The complications are also similar but can be addressed quickly.
Ethics Approval
The research was approved by the institutional ethics committee (No.: IEC/20210049).How to Cite
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
Similar Articles
- Paolo Ruggeri, Abhijit S. Nair, Antonio Esquinas, Comments on “Post severe COVID-19 infection lung damages study. The experience of early three months multidisciplinary follow-up” by De Michele et al. , Monaldi Archives for Chest Disease: Vol. 92 No. 4 (2022)
- Ananda Datta, Satya Padmaja Mantha, Suvradeep Mitra, Prasanta Raghab Mohapatra, M Srikanth Goud, Manoj Kumar Panigrahi, ROS1 positive non-small cell lung cancer with pulmonary embolism in a 22-year woman , Monaldi Archives for Chest Disease: Vol. 90 No. 3 (2020)
- Lilit Khachatryan, Ruzanna Grigoryan, Andrei Dadu, Ajay M.V. Kumar, Kristina Akopyan, Kostyantyn Dumchev, Hasmik Harutyunyan, Alberto Matteelli, Factors associated with unfavourable treatment outcomes among people with rifampicin-resistant tuberculosis in Armenia, 2014-2017 , Monaldi Archives for Chest Disease: Vol. 91 No. 1 (2021)
- Elzahraa Wagdy Abdelfatah, Salwa Hussein Abdelmoneim, Hend Yahia Zakaria, Fatmaalzahraa Saad Abdalrazik, Assessment of diaphragmatic thickness as a predictor for intubation in pneumonia patients , Monaldi Archives for Chest Disease: Early Access
- Marcos Martinelli, Eduardo V. Ponte, Daniel Antunes S. Pereira, Giulio Checchinato , Bruna Eduarda Gandra, Bruno Maciel, Alcides Rocha, Relationship between symptoms and results on spirometry in adults seen in non-tertiary public health facilities presenting with preserved ratio impaired spirometry , Monaldi Archives for Chest Disease: Early Access
- Luigi Pinto, Pietro Schino, Michele Bitetto, Ersilia Tedeschi, Michele Maiellari, Giancarlo De Leo, Elena Ludovico, Giovanni Larizza, Franco Mastroianni, Fibrotic outcomes from SARS-CoV-2 virus interstitial pneumonia , Monaldi Archives for Chest Disease: Early Access
- Unnati Desai, Ketaki Utpat, Aravind Raj, The impact of the COVID-19 pandemic on the profile of interstitial lung disease presenting to the pulmonary medicine department of a tertiary care center in western India , Monaldi Archives for Chest Disease: Early Access
- Gaukhar Kurmanova, Almas Zhanaev, Akzharkyn Kaldybek, Balkiya Abdrakhmanova, Almira Akparova, Impact of the COVID-19 pandemic on the clinical features of patients with chronic obstructive pulmonary disease: an observational cross-sectional study , Monaldi Archives for Chest Disease: Early Access
- Ayshan Mammadova, Zuleyha Galata, Zeynep Yaylçınkaya, Nilgun Yılmaz Demirci, Diagnostic value of pleural fluid and serum C-reactive protein/albumin ratio in exudate/transudate, infectious/non-infectious pleural fluid discrimination , Monaldi Archives for Chest Disease: Early Access
- Erim Bešić, Davorka Muršić, Tajana Jalušić Glunčić, Jelena Ostojić, Sanda Škrinjarić-Cincar, Martina Dokoza, Nataša Karamarković Lazarušić, Miroslav Samaržija, Andrea Vukić Dugac, Prediction of spirometry outcome in Croatian patients with chronic obstructive pulmonary disease , Monaldi Archives for Chest Disease: Early Access
<< < 37 38 39 40 41 42 43 44 45 46 > >>
You may also start an advanced similarity search for this article.
